Dr. Joshua Swamidass joined me to discuss some of his criticisms of Intelligent Design. We talked about his story and the successes and failures of the movement.
It is important that this perspective is being more widely appreciated and respected within the apologetics community.
I just heard that you will be at the Capturing Christianity (CCv2) conference in August. I wish I could attend, but can not. Are you free to say what you will be talking about? Will that session(s) be recorded and available after the conference to view?
One thing you said in the video, Dr. Swamidass, that I would like to hear more about here, is that evolution can get through several unselected steps, re Behe’s last definition of irreducible complexity: “An irreducibly complex evolutionary pathway is one that contains one or more unselected steps (that is, one or more necessary-but-unselected mutations). The degree of irreducible complexity is the number of unselected steps in the pathway.”
Unselected is different than selected-against/deleterious.
The CCC is not about unselectable steps, but about cases where intermediate steps are selected against.
We observe changes with multiple unselected steps all the time in simulations and in laboratory experiments. The rare cases that require strongly deleterious steps may indeed be extremely difficult to evolve. But there is no evidence this is required, for example, in the ape to human transition, as Behe himself acknowledges.
Never mind the fact that there is conclusive evidence that it is not required for the evolution of chloroquine resistance, the very example on which Behe based his CCC concept.
Yes, so then Behe’s edge of evolution, of two new protein-protein binding sites, with 3-4 deleterious steps each, would seem reasonable? Not strongly deleterious steps, necessarily, but deleterious nonetheless…
But Summers et al. state that two mutations seem to be required, on each of two paths, for resistance to develop.
It’s just that no known attribute of any organism is known to require 3-4 deleterious steps. So while we can all imagine some hypothetical hurdle that would prevent evolution, there is no evidence such a hurdle obtains in reality, and we have only found evidence against such hurdles where scientists have looked.
But neither require any deleterious mutations to reach that resistance.
Can you cite any real world adaptations that required 3-4 deleterious steps? If so, can you please cite all of the specific DNA sequences involved and the specific mutations with population data to back up the deleteriousness of the mutations?
I think a great application of Behe’s edge of evolution would be to use cocktails of drugs to combat malaria, for instance, where a double-CCC (chloroquine complexity cluster) would be required to obtain resistance. Since we know the specific DNA sequences etc. in regard to various medicines.
There is evidence they are deleterious (resistance disappearing after removal of chloroquine, resistance arising in 1 in 10^20 organisms), do you have evidence that they are not deleterious?
Why would we even need to do that? Behe thinks double CCC mutations are impossible, so why worry about them? Or are you saying God is going to start using his magic to create resistant bugs, but drug cocktails are more powerful than God?
For anyone who has not been following my earlier attempt to educate Lee, he is basing this on the following paper:
In 1993, Malawi became the first African country to replace chloroquine with sulfadoxine-pyrimethamine nationwide in response to high rates of chloroquine-resistant falciparum malaria. To determine whether withdrawal of chloroquine can lead to the reemergence of chloroquine sensitivity, the prevalence of the pfcrt 76T molecular marker for chloroquine-resistant Plasmodium falciparum malaria was retrospectively measured in Blantyre, Malawi. The prevalence of the chloroquine-resistant pfcrt genotype decreased from 85% in 1992 to 13% in 2000. In 2001, chloroquine cleared 100% of 63 asymptomatic P. falciparum infections, no isolates were resistant to chloroquine in vitro, and no infections with the chloroquine-resistant pfcrt genotype were detected. A concerted national effort to withdraw chloroquine from use has been followed by a return of chloroquine-sensitive falciparum malaria in Malawi. The reintroduction of chloroquine, ideally in combination with another antimalarial drug, should be considered in areas where chloroquine resistance has declined and safe and affordable alternatives remain unavailable.
He believes this shows that the chloroquine resistant strain is subject to strong negative selection. I’m not joking, just ask him.